{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:46:22Z","timestamp":1789541182889,"version":"build-2803163510"},"reference-count":21,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Internet Res"],"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n Social media platforms offer valuable insights into patients\u2019 experience, revealing organic conversations that reflect their immediate concerns and needs. Through active listening to lived experiences, we can identify unmet needs and discover the real-world challenges that patients and caregivers face.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n The aim of our study is to develop a reusable framework to collect and analyze evolving social media data, capturing insights into the experiences of individuals with myelodysplastic syndromes (MDS) and higher-risk MDS and their caregivers. The findings can inform the development of appropriate patient support interventions.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n We conducted a structured Google search of English-language websites relevant to MDS from January 1, 2008, to December 31, 2022, using validated URLs and keywords. Data were sourced from MDS-specific platforms to ensure clinical relevance. Contextual embeddings (rather than simple keyword matching) were applied to detect semantically meaningful mentions of \u201cMDS.\u201d Scraping algorithms collected, cleaned, and standardized the data. Posts were classified as originating from patients or caregivers using decision-tree tagging based on contextual summaries. Users were categorized as HR-MDS based on explicit mentions of \u201chigh-risk\u201d or by referencing criteria aligned with National Comprehensive Cancer Network guidelines (eg, blast count, transplant, chemotherapy use). Each post was analyzed for major themes and sentiment using a supervised machine learning classifier, while latent topics were identified through a semisupervised model.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n We analyzed ~5.5 million words from 42,000 posts across 5500 threads by ~4000 users from the United States, United Kingdom, and Canada. Of the 1249 HR-MDS users identified, 587 (47%) were patients and 662 (53%) were caregivers. Dominant sentiments among HR-MDS users included concern (n=974, 78%), anxiety (n=749, 60%), frustration (n=724, 58%), fear (n=724, 58%), and confusion (n=612, 49%). Concern was the top sentiment among caregivers (n=390, 59%), while anxiety led among patients (n=323, 55%). Key topics included blood counts (n=674, 54%), disease burden (n=537, 43%), quality of life (n=450, 36%), treatment options (n=387, 31%), and disease progression (n=387, 31%). Anxiety was frequently tied to health (n=600, 48%), treatment (n=325, 26%), and the diagnostic process (n=250, 20%). Fear stemmed from complications (n=237, 19%) and progression (n=240, 19%). Confusion about diagnosis and disease understanding was reported by 300 (24%). Information-seeking behaviors revealed user interest in treatment interventions (n=238, 19%) and ongoing research (n=212, 17%).<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n The application of sophisticated natural language processing techniques demonstrates promise in effectively identifying the emerging complex themes and sentiments experienced by HR-MDS users, thereby highlighting the unmet needs, barriers, and facilitators associated with the disease.<\/jats:p>\n <\/jats:sec>","DOI":"10.2196\/65460","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T02:30:10Z","timestamp":1748831410000},"page":"e65460-e65460","source":"Crossref","is-referenced-by-count":3,"title":["Social Media Insights Into Disease Burden in Patients and Caregivers of Myelodysplastic Syndrome: Subcohort Analysis of High-Risk Patients"],"prefix":"10.2196","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-3187-3212","authenticated-orcid":false,"given":"Rohit","family":"Marwah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6615-873X","authenticated-orcid":false,"given":"Subrat","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3871-5311","authenticated-orcid":false,"given":"Benjamin","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Couturiaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9911-1576","authenticated-orcid":false,"given":"Rico","family":"Calara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1993-8165","authenticated-orcid":false,"given":"Eduardo Jose","family":"Sabate Estrella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0686-2395","authenticated-orcid":false,"given":"Cosmina","family":"Hogea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"issue":"20","key":"R1","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1182\/blood-2016-03-657379","article-title":"Introduction to a review series: the 2016 revision of the WHO classification of tumors of hematopoietic and lymphoid tissues","volume":"127","author":"Cazzola","journal-title":"Blood"},{"issue":"2","key":"R2","doi-asserted-by":"publisher","first-page":"106","DOI":"10.6004\/jnccn.2022.0009","article-title":"NCCN Guidelines Insights: Myelodysplastic Syndromes, Version 3.2022","volume":"20","author":"Greenberg","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"R3","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.annonc.2020.11.002","article-title":"Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Fenaux","journal-title":"Ann Oncol"},{"issue":"8","key":"R4","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1200\/JCO.2011.35.6394","article-title":"New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge","volume":"30","author":"Schanz","journal-title":"J Clin Oncol"},{"issue":"7","key":"R5","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2200008","article-title":"Molecular international prognostic scoring system for myelodysplastic syndromes","volume":"1","author":"Bernard","journal-title":"NEJM Evid"},{"issue":"8","key":"R6","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1182\/blood.V90.8.2969","article-title":"Effect of diagnosis (refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, or acute myeloid leukemia [AML]) on outcome of AML-type chemotherapy","volume":"90","author":"Estey","journal-title":"Blood"},{"issue":"8","key":"R7","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1007\/s00277-004-0889-0","article-title":"Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia","volume":"83","author":"Hofmann","journal-title":"Ann Hematol"},{"issue":"21","key":"R8","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1200\/JCO.2012.48.0525","article-title":"Should cytoreductive treatment be performed before transplantation in patients with high-risk myelodysplastic syndrome?","volume":"31","author":"Alessandrino","journal-title":"JCO"},{"issue":"11","key":"R9","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1002\/ajh.25950","article-title":"Myelodysplastic syndromes: 2021 update on diagnosis, risk stratification and management","volume":"95","author":"Garcia\u2010Manero","journal-title":"American J Hematol"},{"issue":"7","key":"R10","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.3324\/haematol.2020.248955","article-title":"Myelodysplastic syndromes: moving towards personalized management","volume":"105","author":"Hellstr\u00f6m-Lindberg","journal-title":"Haematologica"},{"issue":"6","key":"R11","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"Oken","journal-title":"Am J Clin Oncol"},{"issue":"5","key":"R12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","journal-title":"J Chronic Dis"},{"issue":"2","key":"R13","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.soncn.2018.03.003","article-title":"Social media use in cancer care","volume":"34","author":"Watson","journal-title":"Semin Oncol Nurs"},{"issue":"1","key":"R14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-21720-4","article-title":"The language of opinion change on social media under the lens of communicative action","volume":"12","author":"Monti","journal-title":"Sci Rep"},{"issue":"11","key":"R15","doi-asserted-by":"publisher","DOI":"10.2196\/14285","article-title":"Using social media to uncover treatment experiences and decisions in patients with acute myeloid leukemia or myelodysplastic syndrome who are ineligible for intensive chemotherapy: patient-centric qualitative data analysis","volume":"21","author":"Booth","journal-title":"J Med Internet Res"},{"issue":"1","key":"R16","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s12325-022-02277-0","article-title":"Educational and emotional needs of patients with myelodysplastic syndromes: an AI analysis of multi-country social media","volume":"40","author":"Frank","journal-title":"Adv Ther"},{"issue":"11","key":"R17","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1002\/cncr.28631","article-title":"Disparity in perceptions of disease characteristics, treatment effectiveness, and factors influencing treatment adherence between physicians and patients with myelodysplastic syndromes","volume":"120","author":"Steensma","journal-title":"Cancer"},{"issue":"7","key":"R18","first-page":"491","volume":"39","author":"Ventola","journal-title":"P T"},{"key":"R19","unstructured":"MDS Foundation forums. MDS Foundation. URL: https:\/\/www.mds-foundation.org\/forums [Accessed 30-04-2025]"},{"key":"R20","unstructured":"Marrow forums. URL: http:\/\/forums.marrowforums.org [Accessed 30-04-2025]"},{"key":"R21","unstructured":"MDS UK Patient Support Group. URL: https:\/\/mdspatientsupport.org.uk [Accessed 30-04-2025]"}],"container-title":["Journal of Medical Internet Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jmir.org\/2025\/1\/e65460","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:29:39Z","timestamp":1785536979000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jmir.org\/2025\/1\/e65460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":21,"URL":"https:\/\/doi.org\/10.2196\/65460","relation":{},"ISSN":["1438-8871"],"issn-type":[{"value":"1438-8871","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,22]]},"article-number":"v27i20e65460"}}